tradingkey.logo

Ekso Bionics Holdings Inc

EKSO

3.255USD

-0.235-6.73%
Horário de mercado ETCotações atrasadas em 15 min
8.48MValor de mercado
PerdaP/L TTM

Ekso Bionics Holdings Inc

3.255

-0.235-6.73%
Mais detalhes de Ekso Bionics Holdings Inc Empresa
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Informações da empresa
Código da empresaEKSO
Nome da EmpresaEkso Bionics Holdings Inc
Data de listagemApr 10, 2013
CEOMr. Scott G. Davis
Número de funcionários61
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 10
Endereço101 Glacier Point
CidadeSAN RAFAEL
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94901
Telefone15109841761
Sitehttps://eksobionics.com/
Código da empresaEKSO
Data de listagemApr 10, 2013
CEOMr. Scott G. Davis
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
14.90K
+54.55%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
10.58K
+53.05%
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
,
,
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
14.90K
+54.55%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
10.58K
+53.05%
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.78M
52.83%
APAC
491.00K
14.55%
France
422.00K
12.50%
Italy
407.00K
12.06%
Other EMEA
255.00K
7.56%
Other Americas
17.00K
0.50%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 25 de jul
Atualizado em: sex, 25 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Armistice Capital LLC
5.21%
The Vanguard Group, Inc.
1.52%
Li (Kecheng)
1.18%
Lathan (Corinna)
0.98%
Cloyd (Mary Ann)
0.97%
Other
90.15%
Investidores
Investidores
Proporção
Armistice Capital LLC
5.21%
The Vanguard Group, Inc.
1.52%
Li (Kecheng)
1.18%
Lathan (Corinna)
0.98%
Cloyd (Mary Ann)
0.97%
Other
90.15%
Tipos de investidores
Investidores
Proporção
Hedge Fund
5.97%
Individual Investor
5.93%
Investment Advisor
1.85%
Investment Advisor/Hedge Fund
1.75%
Family Office
0.61%
Research Firm
0.07%
Other
83.83%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
69
406.27K
15.56%
+37.52K
2025Q1
74
593.71K
19.55%
+56.61K
2024Q4
73
6.22M
25.06%
-1.22M
2024Q3
72
7.69M
35.95%
+2.06M
2024Q2
75
4.32M
22.05%
+86.91K
2024Q1
79
3.58M
21.92%
+291.20K
2023Q4
84
3.20M
21.39%
-96.00K
2023Q3
87
3.97M
27.62%
+342.40K
2023Q2
88
4.47M
31.89%
+476.23K
2023Q1
90
3.34M
25.52%
-152.01K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Armistice Capital LLC
136.16K
5.79%
+21.12K
+18.35%
Mar 31, 2025
The Vanguard Group, Inc.
39.58K
1.68%
-51.00
-0.13%
Mar 31, 2025
Li (Kecheng)
30.73K
1.31%
+15.75K
+105.11%
May 16, 2025
Lathan (Corinna)
25.61K
1.09%
+15.75K
+159.61%
May 16, 2025
Cloyd (Mary Ann)
25.23K
1.07%
+15.75K
+166.00%
May 16, 2025
Davis (Scott Gerald)
22.27K
0.95%
+7.04K
+46.23%
Mar 18, 2025
Cresset Asset Management, LLC
17.96K
0.76%
-2.04K
-10.17%
Mar 31, 2025
Scher (Deborah Lafer)
15.75K
0.67%
+15.75K
--
May 16, 2025
Jones (Jason C)
14.90K
0.63%
+5.26K
+54.55%
Mar 18, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Data
Tipo
Proporção
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
KeyAI